Board of Directors
Chairman & Managing DirectorGlenn Saldanha
Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Limited. He joined Glenmark Pharmaceuticals in 1998 as Director and took over as Managing Director & CEO in 2001.
As Chairman & Managing Director of Glenmark Pharmaceuticals Limited, Glenn Saldanha oversees all operations of the organization. During his tenure, he transformed Glenmark into a truly global organization with revenue over a billion dollar and commercial presence in over 80 countries. Under his leadership, Glenmark has evolved from an Indian branded generics business, into a research-driven and innovation-led organization. Glenn's vision is to discover, develop and take to market India's first innovative drug for the entire world.
Glenn holds a Bachelor’s Degree in Pharmacy from Mumbai University and is an MBA from the Leonard Stern School of Business at New York University. Prior to Glenmark, he has worked with Eli Lily, USA and PriceWater House Coopers, USA.
Executive DirectorRajesh V Desai
Mr Rajesh V. Desai is the Chief Financial Officer of Glenmark Pharmaceuticals Limited and has been in the organization for close to three decades. A science graduate from Bombay University and a Chartered Accountant from Institute of Chartered Accountants of India, Rajesh is responsible for the Finance, Legal and IT function of the entire organization.
A member of the leadership team for over a decade, Rajesh has been responsible for charting the company's growth in the domestic and overseas markets.
Director – Corporate AffairsCherylann Pinto
Cheryl Pinto is Director - Corporate Affairs with Glenmark Pharmaceuticals Limited from October 1999. She is an executive member of the Board of Directors and belongs to the promoter family of the company.
Having over 20 years of experience in the pharmaceutical field, she presently heads the company’s Human Resource, Corporate Communications and Corporate Social Responsibility functions. As an entrepreneur, Cheryl was the founder of a pharmaceutical company which she served as Managing Director from 1989 to 1999 before joining Glenmark.
Cheryl is a Graduate in Pharmacy from the University Department of Chemical Technology in Mumbai. She has also completed the General Management Programme from the Harvard Business School in Boston.
Non-Executive DirectorBrian W Tempest
Dr. Brian W Tempest is a CSCI, CCHEM, FRSC, BSC, PhD. He has worked in the pharmaceutical industry for the last 40 years and has managed healthcare businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India.
Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional Director, President, Managing Director and Chief Executive Officer until 2005. He then became Chief Mentor, Vice Chairman and Non-Executive Director until 2008 when he retired. He is one of the few Westerners to have led a Sensex Nifty 50 Indian blue chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director-Far East and Regional Director-Middle East & Africa from 1985 to 1992.
Brian received a PhD in Chemistry from Lancaster University in 1971 and in 2009 he became Chairman of the Advisory Board for the Lancaster University Management School . He is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Medicine.
Non-Executive DirectorBernard Munos
Mr. Bernard Munos is the founder of the InnoThink Center for Research in Biomedical Innovation, which was created to translate innovation research into better business models for the pharmaceutical industry and its stakeholders. Before that, he was Advisor for corporate strategy at Eli Lilly and Company where he focused on disruptive innovation and the radical redesign of the R&D model. His research, which has been published in Nature and Science, and was profiled by Forbes Magazine, has helped stimulate a broad rethinking of the pharmaceutical business model by companies, investors, policy-makers, regulators, and patient advocates.
He has presented his findings at numerous meetings sponsored by the National Academies, the Institute of Medicine, the President's Cancer Panel, the NIH Leadership Forum, the World Health Organization, the OECD, the Kauffman Foundation, the US Patent and Trademark Office, Genome Canada, the American Chemical Society, the Council for American Medical Innovation, Science Foundation Ireland, as well as leading universities and think-tanks in the US and Europe.
He received his MBA from Stanford University, and holds other graduate degrees in economics and animal science from the University of California at Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences in France.
Non-Executive DirectorB E Saldanha
Mrs. B. E. Saldanha is a Non-Executive Director and a member of the promoter group of Glenmark Pharmaceuticals Limited. Prior to this position, She was the Director – Exports and managed Glenmark’s international operations from 1982 to 2005. During her 23 year tenure with the organization, she was responsible for developing and growing the company’s export business.
She holds a Bachelors Degree in Science(B.Sc) and a Bachelors Degree in Education( B.Ed.) from Bombay University.
Non-Executive DirectorJulio Ribeiro
Mr. Julio Ribeiro is a retired government official and has served the country under various assignments.
Some of the noteworthy positions that he has held are the Commissioner of Police, Mumbai; Special Secretary to Government of India, Ministry of Home Affairs; Director General of Police, Punjab; Adviser to the Governor of Punjab and Ambassador of India to Romania. At present, he is a Director in IIT Corporate Services Ltd.
Non-Executive DirectorSridhar Gorthi
Mr. Sridhar Gorthi is Non-Executive Director in the organization and is also a Partner in Trilegal, a legal consulting firm. Prior to Trilegal, he worked with Arthur Andersen and Lex Inde, Mumbai. He has been involved in legal advisory services to various multinational and domestic corporations on restructuring, debt finance, joint ventures, acquisitions and mergers.
Mr. Gorthi is a BA. LLB (Hon) from the National Law School of India University.
Non-Executive DirectorMilind Sarwate
Mr. Milind Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm focusing on value creation.
He has over 32 years of experience in Finance, HR, Strategic Planning, Business Development and Product Supply, across various sectors, primarily Consumer Products & Services, in groups such as Marico and Godrej.
He is a Chartered Accountant, Cost Accountant & Company Secretary and a B.Com. (Hon) from the University of Bombay. He is also a CII-Fulbright Fellow, (Carnegie Mellon University, Pittsburgh, PA, USA)
Non-Executive DirectorD R Mehta
Mr. D. R. Mehta, holds a Bachelors Degree in Arts and an LLB degree from the Rajasthan University. He also holds Management Degrees from Royal Institute of Public Administration, London and Alfred Sloan School of Management, Massachusetts Institute of Technology, Boston, United States of America. He was a civil servant for almost forty years and has experience in administration and management of public affairs. He joined the Indian Administrative Services in 1961 and has held positions in the Government of Rajasthan and in the Government of India. He served in the Government of Rajasthan as ‘Collector’ for three districts and Secretary of various departments like Industry, Mines and State enterprises. He was the Joint Secretary (Banking), Controller of Capital Issues and Additional Secretary (Banking) in the Ministry of Finance, Government of India.
He was also the Secretary of the Committee on Financial Policy in the cabinet secretariat in the Government of India. Further, he was the Director General of Foreign Trade in the Government of India, Ministry of Commerce. He was also the Deputy Governor of the Reserve Bank of India and the Chairman of SEBI. He was also the Chairman of the Emerging Markets Committee of the Internat.